Fundraising FoxAttomarker
2 known investors
Find your way into Attomarker
Sign up to see every warm intro you have to Attomarker
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Attomarker team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Attomarker develops rapid diagnostic technologies using nanophotonic testing for healthcare applications. The company, a University of Exeter spinout based in the UK, focuses on precise, real-world blood and health diagnostics.
Founders & leadership
AS
Andrew ShawCEO and FounderAndrew Shaw studied quantum mechanics and spent two years at Stanford before founding EvanesCo, a company focused on counter-terrorism and weapons detection; he later sold a rheumatoid arthritis company and went on to develop biomarker detection technology as a research grant recipient at the University of Exeter, which became the core intellectual property for Attomarker.
Investors · 2
Future Planet Capital✓ confirmed by AttomarkerLondon
How we know: Future Planet Capital's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
Milltrust International GroupreportedLondon · $2.5M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Attomarker do?
- Attomarker develops rapid diagnostic technologies using nanophotonic testing for healthcare applications. The company, a University of Exeter spinout based in the UK, focuses on precise, real-world blood and health diagnostics.
- Who founded Attomarker?
- Attomarker was founded by Andrew Shaw.
- Who are Attomarker's investors?
- Attomarker's investors include Future Planet Capital, Milltrust International Group.